pharmaceutical products, conclusion of non-exclusive drug discount agreements in accordance with section 130a (8) sgb v by way of a so-called open-house model for the active ingredient dienogest / ethinylestradiol (atc code according to who: g03aa16)

supply of pharmaceutical products - health insurance companies (whether hek / hkk participate in the respective lot is determined by the name of the respective lot) pursue the goal of concluding discount agreements with all suitable pharmaceutical compan

pharmaceutical products, the subject of this publication is the conclusion of non-exclusive discount agreements in accordance with section 130a (8) sgb v for drugs containing the active ingredient gefitinib (atc code according to who: l01xe02) as part of

provision of catering services during the international investment and real estate fair expo real 2022 in munich, germany

modules for health purposes and medical equipment - ukraine

expertise internationale pour l"amélioration de la resilience et de la management des crises pour les companies industrie

market study digital film school

senior agricultural finance consultant for elaboration of steering structure and working groups in mozambique

tempered sampler - laboratory, optical and precision equipments (excl. glasses)

building management, bunde secondary school, window renovation, metal construction work